Hexo strikes deal to acquire Zenabis for CA$235 million, eyes European, Canadian cannabis markets
Ottawa, Ontario-headquartered cannabis producer Hexo Corp. on Tuesday entered a definitive agreement to buy struggling competitor Zenabis Global for 235 million Canadian dollars ($185 million) in stock.
Will GW’s multibillion-dollar sale ‘open floodgates’ to pharma-cannabis deal-making?
Jazz Pharmaceuticals’ planned $7.2 billion takeover of United Kingdom-based GW Pharmaceuticals could kick off a wave of deal-making between pharma and medical cannabis companies, analysts and industry sources say.
Medical cannabinoid firm GW Pharma to be acquired by Jazz Pharmaceuticals for $7.2 billion
Global pharma company Jazz Pharmaceuticals has reached an agreement to buy U.K.-based GW Pharmaceuticals, one of the largest medical cannabinoid businesses in the world, for $7.2 billion in cash and stock, the drugmakers announced Wednesday.
France chooses companies to supply free medical cannabis for trial program
The French Agency for the Safety of Medicines and Health Products (ANSM) selected the companies that will supply France’s medical cannabis pilot program that’s intended to provide free products to patients enrolled in the trial.
Czech medical cannabis sales surge, but market remains small
The Czech market for medical cannabis flower quadrupled last year compared to 2019, according to data published by the State Agency for Medical Cannabis.
However, the market remains very small.